PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual
Clinical trial NCT01800305 · COMPLETED
Trial details
- NCT number
- NCT01800305
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-10-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.